Aster DM Healthcare Share Price Aster DM Health.

121.45

Open ()
Turnover (lac)
Prev. Close ()
Day's Vol.(shares)

120.95

Open ()
Turnover (lac)
Prev. Close ()
Day's Vol.(shares)
Detailed Quote

Corporate Action

Period From
Period To
Purpose AGM Date Announcement Date Book Closure Start Date Book Closure End Date
Board Meeting - 08-Jun-2020 - -
Aster DM Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/06/2020 ,inter alia, to consider and approve With reference to captioned subject, we wish to inform you that meeting of the Board of Directors of the Company will be held on Tuesday, June 23, 2020, inter-alia, to consider and approve the Audited Financial Results (both standalone and consolidated) of the Company for the quarter and year ended March 31, 2020. Kindly take the above said information on record. With reference to the captioned subject, we wish to inform you that: 1. The Meeting of the Board of Directors commenced at 11.30 am (IST) and concluded at 3.45 pm (IST). 2. The audited financial results (standalone and consolidated) of the Company for the quarter and year ended March 31, 2020 together with the Auditors Report has been reviewed by the Audit Committee and considered and approved by the Board of Directors. A copy of the audited financial results along with the audit report has been enclosed herewith. 3. The Board of Directors, on recommendation of Nomination and Remuneration Committee, have appointed Mr. James Mathew (DIN:07572909) as an Additional Director (Non-executive Independent). 4. The 12th Annual General Meeting (AGM) of the Company shall be held on August 14, 2020. The cut-off date for determining the eligibility of shareholders to vote on the resolutions proposed at the 12th Annual General Meeting of the Company has been fixed as August 07, 2020. Aster DM Healthcare Ltd has informed BSE about Outcome of Board Meeting held on June 23, 2020. (As Per BSE Announcement dated on 23.06.2020)
Board Meeting - 29-Jan-2020 - -
Quarterly Results Aster DM Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2020 ,inter alia, to consider and approve the unaudited financial results (both standalone and consolidated) of the Company for the quarter ended December 31, 2019 With reference to the captioned subject, we wish to inform you that: 1.The Meeting of the Board of Directors commenced at 11.30 am (IST) and concluded at 3.15 pm (IST). 2.The unaudited financial results (Standalone and Consolidated) of the Company for the quarter ended December 31, 2019 together with the Limited Review Report has been reviewed by the Audit Committee and considered and approved by the Board of Directors, has been enclosed herewith as Annexure-I. Kindly take the above said information on record as per the requirement of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Pursuant to Section 139 of the Companies Act, 2013 and rules made thereunder, it is mandatory for the Company to rotate the current statutory auditors, B S R & Associates LLP, Chartered Accountants, from the conclusion of 12th Annual General Meeting to be held in the year 2020, as they have completed maximum term permitted under the said Section. Accordingly, the Board of Directors of the Company based on the proposal of Audit Committee at its meeting held today, i.e. February 11, 2020, recommended the appointment of Deloitte Haskins & Sells, (Firm Registration No 008072S), Chartered Accountants, as the Statutory Auditor of the Company for a period of 5 (five) consecutive years from the conclusion of 12th Annual General Meeting to be held in the year 2020 till the conclusion of 17th Annual General Meeting to be held in the year 2025, subject to approval of shareholders of the Company. (As Per BSE Announcement Dated 11.02.2020)
Board Meeting - 06-Jan-2020 - -
Aster DM Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/01/2020 ,inter alia, to consider and approve Intimation under Regulation 29 (1)(b) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 We wish to intimate you that the Board of Directors of Aster DM Healthcare Limited will be considering a proposal to buyback its equity shares at a board meeting scheduled to be held on Thursday, January 9, 2020. The outcome of the board meeting will be disseminated to the stock exchanges after conclusion of the said board meeting. We request you to kindly take the above information on record. We refer to our intimation dated January 06, 2020 for considering the Buy-back of Equity shares by the Board of Aster DM Healthcare Limited.We wish to inform you that the Board of Directors of Aster DM Healthcare Limited (the Company) at its meeting held on January 09, 2020 approved a proposal to Buy-back up to 57,14,285 (Fifty seven lakhs fourteen thousand two hundred and eighty five only) equity shares of the Company for an aggregate amount not exceeding Rs. 120 crores (Rupees One Hundred and Twenty Crores only) (the Buyback Size), being 1.13% of the total paid-up equity share capital, at Rs. 210 (Rupees Two Hundred and Ten only) per equity share (the Buyback). (As Per BSE Announcement Dated 09.01.2020)
Board Meeting - 30-Sep-2019 - -
Aster DM Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2019 ,inter alia, to consider and approve Pursuant to Regulation 29 (1) (a) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform that a meeting of the Board of Directors of the Company will be held on Tuesday, November 12, 2019, inter-alia, to consider and approve the unaudited financial results (both standalone and consolidated) of the Company for the quarter and half year ended September 30, 2019. In compliance with SEBI (Prohibition of insider Trading) Regulations, 2015 and the Code for Prevention of Insider Trading adopted by the Company, the designated persons of the Company have been intimated regarding the closure of the trading window which shall commence from October 1, 2019 and end on November 14, 2019 (both days inclusive),48 hours after making the financial results of Q2 of FY 2019-20 available to the general public. Kindly take the same on record. With reference to the captioned subject, we wish to inform you that: 1.The Meeting of the Board of Directors commenced at 12.30 pm (IST) and concluded at 4.45 pm (IST). 2.The unaudited financial results (Standalone and Consolidated) of the Company for the quarter and half year ended September 30, 2019 together with the Limited Review Report has been reviewed by the Audit Committee and considered and approved by the Board of Directors, has been enclosed herewith. 3.Publication of the results in the Newspaper is being done as required under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. 4.The Board of Directors constituted an Investment Committee. The details of the composition of the Investment Committee is given in Annexure I. Kindly take the above said information on record as per the requirement of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. With reference to the captioned subject, please find enclosed unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter and half year ended September 30, 2019 duly reviewed by the Audit Committee and considered and approved by the Board of Directors. Kindly take the above said information on record as per the requirement of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. (As Per BSE Announcement Dated 12.11.2019)
Board Meeting - 18-Jul-2019 - -
Aster DM Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2019 ,inter alia, to consider and approve A meeting of the Board of Directors of the Company will be held on Wednesday, August 7, 2019, inter-alia, to consider and approve the unaudited financial results (both standalone and consolidated) of the Company for the quarter ended June 30, 2019. Kindly take the same on record. With reference to the captioned subject, we wish to inform you that: 1. The Meeting of the Board of Directors commenced at 10.00 am (IST) and concluded at 2.15 pm (IST). 2. The unaudited financial results (Standalone and Consolidated) of the Company for the quarter ended June 30, 2019 along with the Limited Review Report has been enclosed herewith. 3. Publication of the results in the Newspaper is being done as required under the SEBI(LODR)Regulations, 2015. 4. Pursuant to the recommendation of the Nomination and remuneration Committee, Ms. Alisha Moopen has been appointed as the Deputy Managing Director of the Company for a term of 5 years with effect from August 7, 2019, subject to the approval of the Central Government and the Shareholders. 5. The Board has approved the shifting of registered office of the Company from Kochi, Kerala to Bangalore, Karnataka, subject to the approval of the Shareholders. With reference to the captioned subject, we wish to inform that pursuant to the recommendations of the Nomination & Remuneration Committee of the Board, the Board at its meeting held today, i.e., August, 07, 2019, has appointed Ms. Alisha Moopen (DIN: 02432525), currently serving on the Board as a Non-Executive Director, as the Deputy Managing Director of the Company for a period of five years with effect from 7th August 2019, subject to the approval of the shareholders and the Central Government. As a part of the overall succession planning of the Management undertaken for all the key positions in the Company, the Board proposes to appoint Ms. Alisha Moopen as the Deputy Managing Director of the Company. Ms. Alisha is currently CEO of Aster Hospitals and Medcare & Medical Centres - GCC and working closely with Dr. Azad Moopen- Chairman and Managing Director, she shall assume a more challenging role and lead the growth strategy of the Company. (As Per BSE Announcement Dated 07.08.2019)
Board Meeting - 01-Jul-2019 - -
Aster DM Healthcare Ltd has informed BSE about Outcome of Board Meeting held on July 28, 2019.